Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prathibha Mohan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancers|May 28, 2022
Frequent 4EBP1 Amplification Induces Synthetic Dependence on FGFR Signaling in CancerPrathibha Mohan, Joyce Pasion, Giovanni Ciriello, et al.
Cancers|February 10, 2021
NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer TherapyViraj R Sanghvi, Prathibha Mohan, Kamini Singh, et al.
The Journal of Experimental Medicine|May 31, 2019
c-MYC regulates mRNA translation efficiency and start-site selection in lymphomaKamini Singh, Jianan Lin, Yi Zhong, et al.
Cell|August 10, 2019
The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-KinaseViraj R Sanghvi, Josef Leibold, Marco Mina, et al.
Science Signaling|November 20, 2014
Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemiaViraj R Sanghvi, Konstantinos J Mavrakis, Joni Van der Meulen, et al.
JCI Insight|April 7, 2026
Targeting eIF4A-dependent translation in genetically complex sarcomaYoung-Mi Kim, Prathibha Mohan, Urmila Sehrawat, et al.
Cell Reports|June 12, 2026
Mutant KRAS-driven selective mRNA translation reveals mechanisms and therapeutic vulnerabilities in cancerAnkita Shrivastava, Eric Nels Pederson, Trang Uyen Nguyen, et al.
Cancer Research|February 26, 2021
Targeting eIF4A-Dependent Translation of KRAS Signaling MoleculesKamini Singh, Jianan Lin, Nicolas Lecomte, et al.
Nature Cancer|February 11, 2021
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencingSara Parsa, Ana Ortega-Molina, Hsia-Yuan Ying, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancers|May 28, 2022
Frequent 4EBP1 Amplification Induces Synthetic Dependence on FGFR Signaling in CancerPrathibha Mohan, Joyce Pasion, Giovanni Ciriello, et al.
Cancers|February 10, 2021
NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer TherapyViraj R Sanghvi, Prathibha Mohan, Kamini Singh, et al.
The Journal of Experimental Medicine|May 31, 2019
c-MYC regulates mRNA translation efficiency and start-site selection in lymphomaKamini Singh, Jianan Lin, Yi Zhong, et al.
Cell|August 10, 2019
The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-KinaseViraj R Sanghvi, Josef Leibold, Marco Mina, et al.
Science Signaling|November 20, 2014
Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemiaViraj R Sanghvi, Konstantinos J Mavrakis, Joni Van der Meulen, et al.
JCI Insight|April 7, 2026
Targeting eIF4A-dependent translation in genetically complex sarcomaYoung-Mi Kim, Prathibha Mohan, Urmila Sehrawat, et al.
Cell Reports|June 12, 2026
Mutant KRAS-driven selective mRNA translation reveals mechanisms and therapeutic vulnerabilities in cancerAnkita Shrivastava, Eric Nels Pederson, Trang Uyen Nguyen, et al.
Cancer Research|February 26, 2021
Targeting eIF4A-Dependent Translation of KRAS Signaling MoleculesKamini Singh, Jianan Lin, Nicolas Lecomte, et al.
Nature Cancer|February 11, 2021
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencingSara Parsa, Ana Ortega-Molina, Hsia-Yuan Ying, et al.
Pageof 1